|
Physicians Using Bone Density Testing
In The Diagnosis Of Osteoporosis
 |
| Adrian Parker (left), bone density technician,
lines up DEXA equipment to perform a bone density scan on a patient. |
The first indication might be a hip fracture or a broken wrist when grandma takes
a spill on the pavement. It isn’t unusual for women to experience no signs
of osteoporosis until their thin, weakened bones begin to break.
An estimated 28 million Americans are at risk of having osteoporosis, and
80 percent of them are women. Fortunately today’s technology is allowing
physicians like Dr. Howard Nankin to identify and treat osteoporosis earlier
in women before the disease progresses to such complications as a disfiguring
dowager’s hump or a hip fracture that can dramatically impact mortality.
A professor in the Department of Internal Medicine, Dr. Nankin can evaluate
the health of a patient’s bones through bone mineral density testing available
in his department. Using dual energy x-ray absorptiometry (DEXA) equipment, he
and other physicians determine if osteoporosis has resulted in mineral loss and
reduced bone strength in a patient.
“The beauty of DEXA is that we can quantify quite precisely how much
mineral is in the bone,” said Dr. Nankin. “We can see changes well
before they would show up on conventional x-rays.” The spine, hips and
wrists, which are the sites most commonly fractured, are studied in the simple,
painless procedure. “The spine in particular has mainly spongy bone, which
is more vulnerable to losing minerals,” he said. The test results provide
physicians with invaluable diagnostic information. “We can use bone density
testing to tell the patient how they compare with what is considered to be normal
bone density, what their risks are for fracturing bones, and what they can expect
over time,” said Dr. Nankin.
If significant mineral loss is detected through DEXA, physicians can choose
from several drug therapy options that slow down the rate at which the patient
loses bone. A new class of treatment, expected to receive FDA approval in the
next few months, will be the first osteoporosis medication that actually stimulates
new bone formation. Additional DEXA testing can be used with a patient in the
future to monitor the effectiveness of treatment in stabilizing bone loss.
“People ask why we are seeing so much osteoporosis now, and there’s
no pat answer,” Dr. Nankin said. Physicians and researchers speculate on
factors such as a population that’s living longer, less physical activity
on a regular basis, and an increased likelihood of inadequate calcium intake
during the years when it’s most crucial.
“We drink a lot of soft drinks and not enough milk,
especially teenagers. Teens need to absorb huge amounts of calcium to build their
bone mass,” he said, noting that an individual’s peak bone mass occurs
between 25 and 30 years of age.
Dr. Nankin stressed that it’s prudent for women to take a proactive
approach to osteoporosis. Because accelerated mineral loss is associated with
menopause, he recommends that women have a bone density test as they are approaching
menopause, even if they have none of the risk factors associated with osteoporosis. “The
only way to know if you have osteoporosis is by having a bone density test. Once
you get the disease, it is much more difficult to treat it than it is to prevent
it,” he said.
Reprinted from Connections newsletter, September 2003
Connections is produced twice a year by University Specialty Clinics ®. Connections articles
are copyrighted and may be download and/or reprinted for personal use only. Prior
written consent is required in order to reprint or electronically reproduce any
articles, graphics, and photographs appearing on the website. For more information,
contact Diane J. Epperly, Connections editor, at wordchef@atlanticbb.net .
|